Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Fangdi Zou
Institution:
Tianjin Medical University Cancer Institute and Hospital
Observed institutions:
Tianjin Medical University Cancer Institute and Hospital,
Tianjin Medical University
ORCID:
0009-0001-7386-3638
Observed ORCID:
0009-0001-7386-3638
OpenAlex ID:
A5071724360
Generalizable anchor aptamer strategy for loading nucleic acid therapeutics on exosomes
2024
·
Gang Han
, Yao Zhang
, et al.
·
EMBO Molecular Medicine
·
25
PDF
CRTC2 Forms Co-Condensates with YTHDF2 That Enhance Translational Efficiency of m6A-Modified mRNAs to Drive Hepatocarcinogenesis and Lenvatinib Resistance
2025
·
Meixi Wang
, Fangdi Zou
, et al.
·
Cancer Research
·
12
MicroRNA-384 radiosensitizes human non-small cell lung cancer by impairing DNA damage response and repair signaling, which is inhibited by NF-κB
2024
·
Yanchen Sun
, Jing Wang
, et al.
·
Cancer Biology and Medicine
·
9
PDF
Dexlansoprazole prevents pulmonary artery hypertension by inhibiting pulmonary artery smooth muscle cell to fibroblast transition.
2022
·
Qian Jiao
, Fangdi Zou
, et al.
·
PubMed
·
2
Data from CRTC2 Forms Co-Condensates with YTHDF2 That Enhance Translational Efficiency of m6A-Modified mRNAs to Drive Hepatocarcinogenesis and Lenvatinib Resistance
2025
·
Meixi Wang
, Fangdi Zou
, et al.
·
1
DNA-PK-mediated CRTC2 phosphorylation promotes NHEJ and suppresses antitumor immunity via relocation to repair complexes
2026
·
Fangdi Zou
, Zhiqi Yao
, et al.
·
Nature Communications
Figure S1 from CRTC2 Forms Co-Condensates with YTHDF2 That Enhance Translational Efficiency of m6A-Modified mRNAs to Drive Hepatocarcinogenesis and Lenvatinib Resistance
2025
·
Meixi Wang
, Fangdi Zou
, et al.
PDF
Figure S4 from CRTC2 Forms Co-Condensates with YTHDF2 That Enhance Translational Efficiency of m6A-Modified mRNAs to Drive Hepatocarcinogenesis and Lenvatinib Resistance
2025
·
Meixi Wang
, Fangdi Zou
, et al.
PDF
Figure S11 from CRTC2 Forms Co-Condensates with YTHDF2 That Enhance Translational Efficiency of m6A-Modified mRNAs to Drive Hepatocarcinogenesis and Lenvatinib Resistance
2025
·
Meixi Wang
, Fangdi Zou
, et al.
PDF
Figure S14 from CRTC2 Forms Co-Condensates with YTHDF2 That Enhance Translational Efficiency of m6A-Modified mRNAs to Drive Hepatocarcinogenesis and Lenvatinib Resistance
2025
·
Meixi Wang
, Fangdi Zou
, et al.
Figure S10 from CRTC2 Forms Co-Condensates with YTHDF2 That Enhance Translational Efficiency of m6A-Modified mRNAs to Drive Hepatocarcinogenesis and Lenvatinib Resistance
2025
·
Meixi Wang
, Fangdi Zou
, et al.
PDF
Figure S3 from CRTC2 Forms Co-Condensates with YTHDF2 That Enhance Translational Efficiency of m6A-Modified mRNAs to Drive Hepatocarcinogenesis and Lenvatinib Resistance
2025
·
Meixi Wang
, Fangdi Zou
, et al.
PDF
Figure S6 from CRTC2 Forms Co-Condensates with YTHDF2 That Enhance Translational Efficiency of m6A-Modified mRNAs to Drive Hepatocarcinogenesis and Lenvatinib Resistance
2025
·
Meixi Wang
, Fangdi Zou
, et al.
PDF
Figure S7 from CRTC2 Forms Co-Condensates with YTHDF2 That Enhance Translational Efficiency of m6A-Modified mRNAs to Drive Hepatocarcinogenesis and Lenvatinib Resistance
2025
·
Meixi Wang
, Fangdi Zou
, et al.
PDF
Figure S13 from CRTC2 Forms Co-Condensates with YTHDF2 That Enhance Translational Efficiency of m6A-Modified mRNAs to Drive Hepatocarcinogenesis and Lenvatinib Resistance
2025
·
Meixi Wang
, Fangdi Zou
, et al.
Figure S8 from CRTC2 Forms Co-Condensates with YTHDF2 That Enhance Translational Efficiency of m6A-Modified mRNAs to Drive Hepatocarcinogenesis and Lenvatinib Resistance
2025
·
Meixi Wang
, Fangdi Zou
, et al.
PDF
Figure S2 from CRTC2 Forms Co-Condensates with YTHDF2 That Enhance Translational Efficiency of m6A-Modified mRNAs to Drive Hepatocarcinogenesis and Lenvatinib Resistance
2025
·
Meixi Wang
, Fangdi Zou
, et al.
Figure S12 from CRTC2 Forms Co-Condensates with YTHDF2 That Enhance Translational Efficiency of m6A-Modified mRNAs to Drive Hepatocarcinogenesis and Lenvatinib Resistance
2025
·
Meixi Wang
, Fangdi Zou
, et al.
PDF
Table S1 from CRTC2 Forms Co-Condensates with YTHDF2 That Enhance Translational Efficiency of m6A-Modified mRNAs to Drive Hepatocarcinogenesis and Lenvatinib Resistance
2025
·
Meixi Wang
, Fangdi Zou
, et al.
Figure S9 from CRTC2 Forms Co-Condensates with YTHDF2 That Enhance Translational Efficiency of m6A-Modified mRNAs to Drive Hepatocarcinogenesis and Lenvatinib Resistance
2025
·
Meixi Wang
, Fangdi Zou
, et al.
PDF
Figure S5 from CRTC2 Forms Co-Condensates with YTHDF2 That Enhance Translational Efficiency of m6A-Modified mRNAs to Drive Hepatocarcinogenesis and Lenvatinib Resistance
2025
·
Meixi Wang
, Fangdi Zou
, et al.
Show more works
View as search
Works count:
21
Citation count:
49
H-index:
3
I10-index:
2
Year
Topic
Type